Biotech | August 09, 2021
Novavax and Serum Institute submits Emergency Use Authorisation of vaccine to regulatory agencies in India, Indonesia and the Philippines
Filing for WHO Emergency Use Authorisation this month
Filing for WHO Emergency Use Authorisation this month
Advances deployment of mRNA technology across vaccines and therapeutics development
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
The partnership is a significant step in delivering advanced cancer therapies to patients.
Subscribe To Our Newsletter & Stay Updated
